Bharat Immunolog

{
  "main_header": {
    "sid": 936506,
    "name": "Bharat Immunolog",
    "stock_name": "Bharat Immunolog",
    "full_name": "Bharat Immunological & Biological Corporation Ltd",
    "name_url": "stocks-analysis/bharat-immunolog",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 0,
    "country_id": 34,
    "currency": "INR",
    "cmp": "13.79",
    "chg": -0.18,
    "chgp": "-1.29%",
    "dir": -1,
    "prev_price": "13.97",
    "mcapval": "59.55 Cr",
    "mcap": "Micro Cap",
    "scripcode": 524663,
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "sector_id": 65,
    "indexname": "India SENSEX",
    "isin": "INE994B01014",
    "curr_date": "Sep 23, 10:52 AM",
    "curr_time": "10:53 AM",
    "last_traded_at": "Sep 23, 10:52 AM IST",
    "bse_nse_vol": "9.64 k",
    "exc_status": "Active",
    "traded_date": "Sep 23, 2026",
    "traded_date_str": "2026 09 23",
    "score": "",
    "scoreText": "",
    "Live": 1,
    "market_time": 1,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/bharat-immunolog-936506-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Bharat Immunological & Biological Corporation Ltd Falls to 52-Week Low of Rs 13.96 as Sell-Off Deepens",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/bharat-immunological-biological-corporation-ltd-falls-to-52-week-low-of-rs1396-4200027",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/BharatImmunolog_priceRelatedfactors_4200027.png",
        "date": "2026-09-21 13:06:50",
        "description": "For the third consecutive session, Bharat Immunological & Biological Corporation Ltd has seen its share price decline, culminating in a fresh 52-week low of Rs 13.96 on 21 Sep 2026. This marks a significant 38.2% drop from its 52-week high of Rs 22.61, underscoring persistent selling pressure despite a broadly positive market backdrop."
      },
      {
        "title": "Bharat Immunological & Biological Corporation Ltd Falls to 52-Week Low of Rs 14.06 as Sell-Off Deepens",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/bharat-immunological-biological-corporation-ltd-hits-52-week-low-amidst-continued-downtrend-4197290",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/BharatImmunolog_priceRelatedfactors_4197290.png",
        "date": "2026-09-18 10:13:06",
        "description": "A sharp decline in Bharat Immunological & Biological Corporation Ltd shares has pushed the stock to a fresh 52-week low of Rs 14.06 on 18 Sep 2026, marking a 7.21% drop over the past two sessions amid continued underperformance relative to its sector and benchmark indices."
      },
      {
        "title": "Bharat Immunological & Biological Corporation Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/bharat-immunological-biological-corporation-ltd-is-rated-strong-sell-4196209",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/BharatImmunolog_mojoScore_4196209.png",
        "date": "2026-09-17 10:10:56",
        "description": "Bharat Immunological & Biological Corporation Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 09 April 2024. However, the analysis and financial metrics discussed here reflect the stock's current position as of 17 September 2026, providing investors with an up-to-date view of the company’s performance and outlook."
      },
      {
        "title": "Bharat Immunological & Biological Corporation Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/bharat-immunological-biological-corporation-ltd-is-rated-strong-sell-4182423",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/BharatImmunolog_mojoScore_4182423.png",
        "date": "2026-09-04 10:10:46",
        "description": "Bharat Immunological & Biological Corporation Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 09 April 2024. However, the analysis and financial metrics discussed below reflect the company’s current position as of 04 September 2026, providing investors with an up-to-date view of the stock’s fundamentals, valuation, financial trend, and technical outlook."
      },
      {
        "title": "Bharat Immunological & Biological Corporation Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/bharat-immunological-biological-corporation-ltd-is-rated-strong-sell-4166772",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/BharatImmunolog_mojoScore_4166772.png",
        "date": "2026-08-24 10:10:49",
        "description": "Bharat Immunological & Biological Corporation Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 09 April 2024. However, the analysis and financial metrics discussed here reflect the stock's current position as of 24 August 2026, providing investors with the latest insights into the company’s performance and outlook."
      },
      {
        "title": "Bharat Immunological & Biological Corporation Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/bharat-immunological-biological-corporation-ltd-is-rated-strong-sell-4151670",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/BharatImmunolog_mojoScore_4151670.png",
        "date": "2026-08-13 10:11:00",
        "description": "Bharat Immunological & Biological Corporation Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 09 April 2024, reflecting a significant reassessment of the stock’s outlook. However, the analysis and financial metrics presented here are based on the company’s current position as of 13 August 2026, providing investors with the latest insights into its performance and prospects."
      },
      {
        "title": "Bharat Immunological & Biological Corporation Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/bharat-immunological-biological-corporation-ltd-is-rated-strong-sell-4132311",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/BharatImmunolog_mojoScore_4132311.png",
        "date": "2026-08-02 10:10:16",
        "description": "Bharat Immunological & Biological Corporation Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 09 April 2024, reflecting a significant reassessment of the stock’s outlook. However, the analysis below is based on the company’s current fundamentals, returns, and financial metrics as of 02 August 2026, providing investors with an up-to-date perspective on its investment potential."
      },
      {
        "title": "Bharat Immunological & Biological Corporation Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/bharat-immunological-biological-corporation-ltd-is-rated-strong-sell-4112437",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/BharatImmunolog_mojoScore_4112437.png",
        "date": "2026-07-21 10:10:29",
        "description": "Bharat Immunological & Biological Corporation Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 09 Apr 2024. However, the analysis and financial metrics presented here reflect the company’s current position as of 21 July 2026, providing investors with an up-to-date view of the stock’s fundamentals, returns, and overall outlook."
      },
      {
        "title": "Bharat Immunological & Biological Corporation Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/bharat-immunological-biological-corporation-ltd-is-rated-strong-sell-4095056",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/BharatImmunolog_mojoScore_4095056.png",
        "date": "2026-07-09 10:10:26",
        "description": "Bharat Immunological & Biological Corporation Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 09 April 2024, reflecting a significant reassessment of the stock’s outlook. However, the analysis below presents the company’s current position as of 09 July 2026, incorporating the latest fundamentals, returns, and financial metrics to provide investors with an up-to-date perspective."
      }
    ],
    "total": 110,
    "sid": "936506",
    "stock_news_url": "https://www.marketsmojo.com/news/bharat-immunological-biological-corporation-936506"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Winding-up",
      "datetime": "17-Sep-2026",
      "details": "Pursuant to the Regulation 30 and other applicable Regulation(s) of SEBI LODR It is informed that the Government of India has approved the closure of Bharat Immunologicals and Biologicals Corporation Limited (BIBCOL) under Administrative control of Department of Biotechnology Ministry of Science & Technology Government of India. This information is being submitted with reference to the communication received on 17.09.2026 from Department of Biotechnology.",
      "source": "BSE"
    },
    {
      "caption": "Board Meeting Intimation for Intimation Of Date Of Board Meeting On 16.08.2024 Under Regulation 29 Of SEBIS LODR.",
      "datetime": "07-Aug-2024",
      "details": "BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION LTD.-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 16/08/2024 inter alia to consider and approve Pursuant to the Regulation 29 and other applicable Regulation(s) of Securities and Exchange Board of India (Listing Obligation and Disclosure Requirements) Regulations 2015 it is informed that a meeting of the Board of Directors of the Company is scheduled to be held on Friday 16th August 2024 for General Purpose.",
      "source": "BSE"
    },
    {
      "caption": "Board Meeting Intimation for Intimation Of Date Of Board Meeting On 08.03.2024 Under Regulation 29 Of SEBIS LODR.",
      "datetime": "29-Feb-2024",
      "details": "BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION LTD.-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/03/2024 inter alia to consider and approve Pursuant to the Regulation 29 and other applicable Regulation(s) of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015 it is informed that a meeting of the Board of Directors of the Company is scheduled to be held on Friday 08th March 2024 for General Purpose.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Bharat Immunological & Biological Corporation Ltd Falls to 52-Week Low of Rs 13.96 as Sell-Off Deepens

2026-09-21 13:06:50

For the third consecutive session, Bharat Immunological & Biological Corporation Ltd has seen its share price decline, culminating in a fresh 52-week low of Rs 13.96 on 21 Sep 2026. This marks a significant 38.2% drop from its 52-week high of Rs 22.61, underscoring persistent selling pressure despite a broadly positive market backdrop.

Read full news article

Bharat Immunological & Biological Corporation Ltd Falls to 52-Week Low of Rs 14.06 as Sell-Off Deepens

2026-09-18 10:13:06

A sharp decline in Bharat Immunological & Biological Corporation Ltd shares has pushed the stock to a fresh 52-week low of Rs 14.06 on 18 Sep 2026, marking a 7.21% drop over the past two sessions amid continued underperformance relative to its sector and benchmark indices.

Read full news article

Bharat Immunological & Biological Corporation Ltd is Rated Strong Sell

2026-09-17 10:10:56

Bharat Immunological & Biological Corporation Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 09 April 2024. However, the analysis and financial metrics discussed here reflect the stock's current position as of 17 September 2026, providing investors with an up-to-date view of the company’s performance and outlook.

Read full news article

Bharat Immunological & Biological Corporation Ltd is Rated Strong Sell

2026-09-04 10:10:46

Bharat Immunological & Biological Corporation Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 09 April 2024. However, the analysis and financial metrics discussed below reflect the company’s current position as of 04 September 2026, providing investors with an up-to-date view of the stock’s fundamentals, valuation, financial trend, and technical outlook.

Read full news article

Bharat Immunological & Biological Corporation Ltd is Rated Strong Sell

2026-08-24 10:10:49

Bharat Immunological & Biological Corporation Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 09 April 2024. However, the analysis and financial metrics discussed here reflect the stock's current position as of 24 August 2026, providing investors with the latest insights into the company’s performance and outlook.

Read full news article

Bharat Immunological & Biological Corporation Ltd is Rated Strong Sell

2026-08-13 10:11:00

Bharat Immunological & Biological Corporation Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 09 April 2024, reflecting a significant reassessment of the stock’s outlook. However, the analysis and financial metrics presented here are based on the company’s current position as of 13 August 2026, providing investors with the latest insights into its performance and prospects.

Read full news article

Bharat Immunological & Biological Corporation Ltd is Rated Strong Sell

2026-08-02 10:10:16

Bharat Immunological & Biological Corporation Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 09 April 2024, reflecting a significant reassessment of the stock’s outlook. However, the analysis below is based on the company’s current fundamentals, returns, and financial metrics as of 02 August 2026, providing investors with an up-to-date perspective on its investment potential.

Read full news article

Bharat Immunological & Biological Corporation Ltd is Rated Strong Sell

2026-07-21 10:10:29

Bharat Immunological & Biological Corporation Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 09 Apr 2024. However, the analysis and financial metrics presented here reflect the company’s current position as of 21 July 2026, providing investors with an up-to-date view of the stock’s fundamentals, returns, and overall outlook.

Read full news article

Bharat Immunological & Biological Corporation Ltd is Rated Strong Sell

2026-07-09 10:10:26

Bharat Immunological & Biological Corporation Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 09 April 2024, reflecting a significant reassessment of the stock’s outlook. However, the analysis below presents the company’s current position as of 09 July 2026, incorporating the latest fundamentals, returns, and financial metrics to provide investors with an up-to-date perspective.

Read full news article

View All News